Gliclazide and Levocarnitine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gliclazide (gliclazide) and Levocarnitine (levocarnitine). Common drug interactions include disability among females and angina unstable among males.

The phase IV clinical study analyzes what interactions people have when they take Gliclazide and Levocarnitine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

On Aug, 07, 2026

13 people who take Gliclazide and Levocarnitine together, and have interactions are studied.

Gliclazide and Levocarnitine drug interactions.

What are the common drug interactions of Gliclazide and Levocarnitine, by gender? *:

female:

Disability
Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
Muscle disorder (muscle disease)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Death
Drug level decreased
Hepatic enzyme decreased
Hypertension (high blood pressure)
Hypophagia (reduced food intake)
Palpitations (feelings or sensations that your heart is pounding or racing)

male:

Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Death
Tumour haemorrhage (bleeding from tumour)

What are the common drug interactions of Gliclazide and Levocarnitine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Drug level decreased

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Death
Tumour haemorrhage (bleeding from tumour)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 61.54%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 38.46%
Stable Angina (a constant chest pain): 2 people, 15.38%
Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Gout (uric acid crystals building up in the body): 2 people, 15.38%
Dizziness: 2 people, 15.38%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 15.38%
Constipation: 2 people, 15.38%
Chest Pain: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and Levocarnitine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously